Introduction
Vitamin D, especially its most active metabolite 1,25 dihydroxyvitamin D 3 , plays an important role not only in calcium homeostasis and bone remodeling, but also in the control of hormone secretion, immune dysfunction, cellproliferation and differentiation. 1 During pregnancy, maternal serum concentrations of 25(OH) D 3 , the circulating form of vitamin D, correlate with dietary vitamin D intake. 2 Maternal serum concentrations of 1,25-dihydroxyvitamin D 3 , the hormonal circulating and active from of vitamin D, are elevated during pregnancy. 2 During the intrauterine development, 1,25-dihydroxyvitamin D 3 is synthesized mainly by the decidual cells of the placenta and allows for increased calcium absorption. The fetus is entirely dependent on the mother for an adequate supply of 25(OH)D 3 , which is believed to cross the placenta. 3 Hypocalcemia and increased parathyroid hormone secretion induce synthesis of 1,25-dihydroxyvitamin D after birth in both full term and preterm neonates. Nevertheless, serum concentrations of 25(OH)D 3 , a rate limiting factor in the synthesis of 1,25-dihydroxyvitamin D concentration, are higher than those observed in older infants. 4 In countries where dairy products are not routinely supplemented with vitamin D, maternal vitamin D supplementation during pregnancy is necessary. 5 Maternal total serum calcium concentration declines progressively throughout pregnancy and reaches a nadir of 2-2.2 mmol/L by the 2 nd month. 4 Because 50% of calcium is bound to serum albumin, hypoalbuminemia resulting from expansion of the extracellular volume partly account for this decrease. In contrast, serum ionized calcium concentration undergoes minimal changes. As mentioned above, serum 25(OH)D 3 concentration varies according to vitamin D intake and synthesis, season, and geographical location. 6 Low maternal vitamin D levels during pregnancy have been linked to various health outcomes in the offspring, including a higher incidence of abortion, low birth weight, neonatal hypocalcemia, impaired development and rickets. 1, 7 The aim of the current study is to assess the effect of maternal vitamin D status on neonatal vitamin D stores.
Materials and Methods
This case-control study was carried out at Al Khafji Joint Operation Hospital, Saudi Arabia. Initially, the study enrolled 118 pregnant women and their newborns, during the year 2011. Twenty-six women were excluded from the study either due to delivery outside the hospital, delivery of a non-full term baby, or failure to obtain a neonatal blood sample. Therefore, a total of only 92 women and their newborn infants were actually included in the study.
Inclusion criteria
The study included healthy women between 20 and 40 years of age and singleton full term pregnancies.
Exclusion criteria
Those women with a history of thyroid or parathyroid diseases, diabetes mellitus, or any kind of calcium or vitamin D supplements in the current pregnancy were excluded. Neonates with congenital anomalies or who were small for gestational age (SGA) were also excluded, as were, retrospectively, their mothers. All women participating in the study provided their written informed consent in accordance with the Declaration of Helsinki. During their regular antenatal visits, the participating women were requested to complete a questionnaire that included obstetric history, sociodemographic data, dietary habits, life style and calcium or vitamin D supplements. Maternal pre-pregnancy body mass index (BMI) was calculated according to height measured at recruitment and self-reported pre-pregnancy weight. Of the 92 women included in the study, 64 had risk factors of vitamin D deficiency (less exposure to sunshine, more work indoors, less intake of diary products, dark skin, veiled clothing). The remaining women were considered as a comparison group.
Newborn clinical examination and anthropometric measurements including weight, length, and head circumference were performed at birth.
Laboratory measurements
Measurement of serum 25(OH)D 3: : 2 mL of venous blood were collected from each mother at the end of the 3 rd trimester as well as 3 mL of cord blood from each neonate in EDTA-containing tubes and centrifuged at 3000 rpm for 10 min. Serum was separated and stored as 1 mL aliquots at -20ºC until analysis. Serum level of 25(OH)D 3 was measured after extraction using the immunodiagnostic enzyme immuno-assay (EIA) developed by Immuno-diagnostic, Bensheim and Biomedica, Wien, Australia. 8 Cut-off levels of vitamin D were distinguished as follows: <30 nmol/L deficient, 30-50 nmol/L insufficient, and 50 nmol/L adequate. 9,10 Serum PO 4 and Ca ++ levels were estimated according to Kalliomaki JL et al. 11 Serum ALP was assayed according to Berth and Delanghe. 12 
Statistical analysis
Data were presented as mean ± standard deviation (X±SD) or percentage (%). The means of two groups were compared using Student's t-test. Linear correlation and regression were used to test the correlation between the measured parameters. Cut-off values were calculated from the receiver operating characteristics (ROC) curve as mean ± 2 SD of control. Data were tabulated and statistically analyzed with the statistical package for Social Sciences (SPSS) version 14 software. P<0.05 was considered significant. 13 
Results
The study included 92 pregnant women aged 20- Table 2) . Despite lower vitamin D concentration in women with risk factors, there was no significant difference in serum calcium and phosphorus between the mothers' groups (P>0.01). On the other hand, the mean serum ALP was found to be significantly higher in mothers with risk factors for vitamin D deficiency than in those without risk factors (P<0.05) ( Table 2) .
Among the newborn infants of mothers with risk factors of vitamin D deficiency, vitamin D concentrations were found to be significantly lower than newborns of mothers without risk (33.44±18.33 vs 55.39±17.37 nmol/L; P<0.01). As regards the neonatal serum biochemical markers, serum calcium levels were found to be significantly lower in neonates of mothers with risk factors of vitamin D deficiency than those in neonates of mothers without risk factors (8.04±0.47 vs 9.07±0.62 mg/DL; P<0.05). Meanwhile, serum phosphorus and alkaline phosphatase were significantly higher in neonates of mothers with risk factors of vitamin D deficiency (Table 3) .
A positive linear relationship was found between circulating concentrations of maternal 25(OH)D 3 in pregnancy and both serum calcium (r=0.81, P=0.01) and serum phosphorus (r=0.88, P=0.01) levels. On other hand, it correlates negatively with serum alkaline phosphatase (r=-0.98, P=0.01) as shown in Table 4 . Cord blood serum levels of 25(OH)D 3 correlated negatively with both serum alkaline phosphatase (r=-0.74, P=0.01) and serum phosphorus levels (r=-0.82, P<0.05), while it significantly correlated positively with serum calcium levels (r=0.72, P=0.01) ( atively with alkaline phosphatase (r=-0.78, P=0.01) ( Table 6 ).
Discussion
Vitamin D deficiency is a public health issue worldwide. 14 In most countries, there is no routine monitoring of serum 25(OH)D 3 levels during pregnancy. A 2009 review has recommended that women with one or more risk factors for low serum 25(OH)D 3 should be monitored at the beginning of gestation and in midpregnancy. 15 In the current study of women at high risk for vitamin D deficiency, women with low socio-economic state, women with history of inadequate sun exposure, and women with two or more previous births were significantly more likely to have lower 25(OH)D 3 concentrations compared with those of higher socio-economic state, adequate sun exposure, and women with one previous birth respectively (P<0.05). Similar results were also reported by Merewood et al. 16 and Shand et al. 17 Also, women from rural areas had lower vitamin D than women from urban areas, while there were no significant associations between 25(OH)D 3 concentration and BMI or maternal age. Merewood et al. 16 reported that there was no difference in maternal plasma concentrations of 25(OH)D 3 according to maternal prepregnancy BMI, social class or education level. In the current study, there was a significant difference in the prevalence of 25(OH)D 3 deficiency between mothers at high risk of vitamin D deficiency compared with a group presumed not to be at risk. This is in contrast to that of Dijkstra et al. 18 The current study revealed significantly higher levels of maternal serum alkaline phosphatase in mothers with risk factors of vitamin D deficiency compared with mothers not at risk. This can be attributed to the lower serum 25(OH)D 3 levels. 6 Newborns of mothers at risk of vitamin D deficiency had lower cord blood 25(OH)D 3 than a group of mothers not at risk. Similarly, Namgung et al. 19 revealed that newborns born to mothers in winter with inadequate sun exposure had low 25(OH)D 3 compared with those in summer newborns. Among the newborns of mothers with risk of vitamin D deficiency, serum alkaline phosphatase concentrations were found to be significantly higher than newborns of moth- 21 reported elevated ALP in 13% and hypocalcemia in 44% of their pregnant subjects who were not receiving vitamin D supplementation, whereas none of the subjects supplemented with vitamin D (600,000 IU twice in the 7 th and 8 th months of gestation) had elevated ALP. 22 The present study identified a significant positive correlation between cord blood 25(OH)D 3 and serum calcium concentrations. Given a limited 25(OH)D 3 substrate availability, the fetal kidneys can try to overcome this deficiency by increasing the rate of production of active form of vitamin D and, theoretically, this could be a factor affecting placental calcium transfer and fetal bone mineralization. 23 Also, many studies report that maternal vitamin D concentration plays a crucial role in neonatal and maternal calcium homeostasis, and that infants of mothers with low vitamin D intake during pregnancy had low serum calcium concentrations in cord blood or during the first week of life. 24 Our results added to the evidence that, serum 25(OH)D 3 in pregnant mothers correlated with cord blood vitamin D, as reported by other several studies. [25] [26] [27] This study has some limitations. First, only a single 25(OH)D 3 measurement per subject was available and this can not reflect the maternal long-term status during the entire pregnancy. Second, estimating 25(OH)D 3 concentrations did not take into consideration the season.
Article

Conclusions
Vitamin D deficiency was common among high-risk women and their newborn infants. Further research is required to determine the levels of vitamin D 3 at different gestations and the dose of vitamin D to ensure adequate 25(OH)D 3 levels in pregnancy. Given the strong correlation of maternal 25(OH)D 3 with cord blood and neonatal 25(OH)D 3 , and the known risks for neonates associated with low maternal 25(OH)D 3 we suggest routine testing of 25(OH)D 3 early in the antenatal period, especially for those with risk factors, and treatment of women found to be vitamin D deficient to avoid neonatal morbidities.
